Apellis Pharmaceuticals Accounts Receivable (Quarterly) Analysis

Apellis Pharmaceuticals Inc (APLS)

42.00 -0.56 (-1.32%) USD | NASDAQ | Jun 14, 16:00

42.00 0.00 (0.00%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	267.84M
December 31, 2023	206.44M
September 30, 2023	169.26M
June 30, 2023	110.91M
March 31, 2023	31.50M
December 31, 2022	7.727M
September 30, 2022	8.091M

Date	Value
June 30, 2022	7.518M
March 31, 2022	6.33M
December 31, 2021	10.10M
September 30, 2021	3.522M
June 30, 2021	0.719M
March 31, 2021
December 31, 2020	0.00

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

Minimum

Dec 2020

267.84M

Maximum

Mar 2024

63.84M

Average

8.091M

Median

Sep 2022

Accounts Receivable (Quarterly) Benchmarks